-Martijn Schenning Researcher Activity Profile

Research Author Detailed Information 

Martijn Schenning Publication Rate By Year

Martijn Schenning has published 3 paper(s) in 2007, 2 paper(s) in 2008, for a total of 5 research publications in total.

Martijn M Schenning Author Information

LAST NAME: schenning

FIRST NAME: Martijn

INITIALS: m

AFFILIATION:

Papers

Martijn Schenning's Publication Record

1. The anti-apoptotic MAP kinase pathway is inhibited in NIH3T3 fibroblasts with increased expression of phosphatidylinositol transfer protein beta. Year Published: 2007
Bijvoet Center, Department of Biochemistry of Lipids, Institute of Biomembranes, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands.
2. The anti-apoptotic MAP kinase pathway is inhibited in NIH3T3 fibroblasts with increased expression of phosphatidylinositol transfer protein beta. Year Published: 2007
Bijvoet Center, Department of Biochemistry of Lipids, Institute of Biomembranes, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands. MSchenning@dundee.ac.uk
3. The anti-apoptotic MAP kinase pathway is inhibited in NIH3T3 fibroblasts with increased expression of phosphatidylinositol transfer protein beta. Year Published: 2007
Bijvoet Center, Department of Biochemistry of Lipids, Institute of Biomembranes, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands. MSchenning@dundee.ac.uk
4. Distinct activities of novel neurotoxins from Australian venomous snakes for nicotinic acetylcholine receptors. Year Published: 2008
The Queensland Cancer Fund Research Unit, The Queensland Institute of Medical Research, P.O. Box Royal Brisbane Hospital, Herston, Brisbane, 4029, Australia.
5. Distinct activities of novel neurotoxins from Australian venomous snakes for nicotinic acetylcholine receptors. Year Published: 2008
The Queensland Cancer Fund Research Unit, The Queensland Institute of Medical Research, P.O. Box Royal Brisbane Hospital, Herston, Brisbane, 4029, Australia.